Drug class
Quaternary ammonium antimuscarinic antispasmodic
Mechanism of action
The pipethanate cation produces antimuscarinic smooth-muscle relaxation by antagonising acetylcholine-mediated muscarinic receptor signalling in the gastrointestinal tract. Ethobromide is the counter-ion; it does not create a different API pharmacology.
General use cases
- Symptomatic relief of gastrointestinal smooth-muscle spasm in countries where pipethanate products are authorised; current product status and precise indications require confirmation from local product information
Pipethanate is the pharmacologically active antispasmodic cation; bromide is the counter-ion. Do not assign a distinct indication solely because of the bromide salt.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
